Trust Company of Vermont’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.56M | Buy |
+12,339
| New | +$1.63M | 0.06% | 183 |
|
|
2025
Q4 | $1.47M | Sell |
11,985
-115
| -1% | -$14K | 0.06% | 170 |
|
|
2025
Q3 | $1.34M | Buy |
12,100
+124
| +1% | +$14.1K | 0.06% | 175 |
|
|
2025
Q2 | $1.33M | Buy |
11,976
+320
| +3% | +$34.1K | 0.06% | 169 |
|
|
2025
Q1 | $1.31M | Sell |
11,656
-70
| -0.6% | -$7.22K | 0.07% | 169 |
|
|
2024
Q4 | $1.08M | Buy |
11,726
+2,176
| +23% | +$196K | 0.05% | 179 |
|
|
2024
Q3 | $801K | Sell |
9,550
-423
| -4% | -$32.3K | 0.04% | 193 |
|
|
2024
Q2 | $684K | Buy |
9,973
+31
| +0.3% | +$2.07K | 0.04% | 203 |
|
|
2024
Q1 | $728K | Buy |
9,942
+456
| +5% | +$35.1K | 0.04% | 199 |
|
|
2023
Q4 | $768K | Buy |
9,486
+1,220
| +15% | +$94.9K | 0.05% | 182 |
|
|
2023
Q3 | $619K | Buy |
8,266
+1,139
| +16% | +$87.6K | 0.04% | 197 |
|
|
2023
Q2 | $549K | Buy |
7,127
+2,500
| +54% | +$199K | 0.04% | 214 |
|
|
2023
Q1 | $384K | Sell |
4,627
-34
| -0.7% | -$2.82K | 0.03% | 248 |
|
|
2022
Q4 | $400K | Sell |
4,661
-1,281
| -22% | -$101K | 0.03% | 238 |
|
|
2022
Q3 | $366K | Buy |
5,942
+1,272
| +27% | +$80.2K | 0.03% | 235 |
|
|
2022
Q2 | $288K | Sell |
4,670
-341
| -7% | -$21.1K | 0.02% | 260 |
|
|
2022
Q1 | $297K | Buy |
5,011
+60
| +1% | +$3.83K | 0.02% | 268 |
|
|
2021
Q4 | $359K | Sell |
4,951
-1,193
| -19% | -$82.2K | 0.02% | 259 |
|
|
2021
Q3 | $430K | Sell |
6,144
-240
| -4% | -$16.9K | 0.03% | 230 |
|
|
2021
Q2 | $439K | Sell |
6,384
-2,146
| -25% | -$143K | 0.03% | 232 |
|
|
2021
Q1 | $551K | Sell |
8,530
-1,662
| -16% | -$107K | 0.04% | 212 |
|
|
2020
Q4 | $594K | Sell |
10,192
-1,456
| -13% | -$87.9K | 0.05% | 190 |
|
|
2020
Q3 | $736K | Sell |
11,648
-500
| -4% | -$34.7K | 0.07% | 170 |
|
|
2020
Q2 | $934K | Sell |
12,148
-4,343
| -26% | -$333K | 0.09% | 156 |
|
|
2020
Q1 | $1.23M | Sell |
16,491
-6,060
| -27% | -$419K | 0.12% | 141 |
|
|
2019
Q4 | $1.47M | Sell |
22,551
-8,772
| -28% | -$571K | 0.11% | 147 |
|
|
2019
Q3 | $1.99M | Sell |
31,323
-3,369
| -10% | -$220K | 0.16% | 121 |
|
|
2019
Q2 | $2.34M | Sell |
34,692
-2,048
| -6% | -$135K | 0.19% | 105 |
|
|
2019
Q1 | $2.39M | Sell |
36,740
-2,583
| -7% | -$172K | 0.21% | 104 |
|
|
2018
Q4 | $2.46M | Sell |
39,323
-4,906
| -11% | -$343K | 0.24% | 98 |
|
|
2018
Q3 | $3.42M | Buy |
44,229
+1,161
| +3% | +$87.7K | 0.29% | 90 |
|
|
2018
Q2 | $3.05M | Buy |
43,068
+1,158
| +3% | +$81.8K | 0.27% | 95 |
|
|
2018
Q1 | $3.16M | Buy |
41,910
+267
| +0.6% | +$21.2K | 0.3% | 93 |
|
|
2017
Q4 | $2.98M | Buy |
41,643
+54
| +0.1% | +$4.1K | 0.28% | 99 |
|
|
2017
Q3 | $3.37M | Buy |
41,589
+10
| +0% | +$765 | 0.34% | 90 |
|
|
2017
Q2 | $2.94M | Sell |
41,579
-2,446
| -6% | -$163K | 0.3% | 93 |
|
|
2017
Q1 | $2.99M | Buy |
44,025
+1,644
| +4% | +$116K | 0.32% | 91 |
|
|
2016
Q4 | $3.04M | Sell |
42,381
-9,731
| -19% | -$723K | 0.35% | 82 |
|
|
2016
Q3 | $4.12M | Buy |
52,112
+3,201
| +7% | +$260K | 0.52% | 66 |
|
|
2016
Q2 | $4.08M | Sell |
48,911
-2,482
| -5% | -$220K | 0.54% | 64 |
|
|
2016
Q1 | $4.72M | Buy |
51,393
+2,106
| +4% | +$190K | 0.66% | 52 |
|
|
2015
Q4 | $4.99M | Buy |
49,287
+4,293
| +10% | +$447K | 0.71% | 47 |
|
|
2015
Q3 | $4.42M | Buy |
44,994
+8,828
| +24% | +$980K | 0.69% | 47 |
|
|
2015
Q2 | $4.23M | Buy |
36,166
+3,608
| +11% | +$394K | 0.62% | 51 |
|
|
2015
Q1 | $3.19M | Buy |
32,558
+5,738
| +21% | +$583K | 0.46% | 67 |
|
|
2014
Q4 | $2.53M | Buy |
26,820
+517
| +2% | +$53.5K | 0.37% | 85 |
|
|
2014
Q3 | $2.8M | Buy |
26,303
+304
| +1% | +$29.8K | 0.42% | 74 |
|
|
2014
Q2 | $2.15M | Buy |
25,999
+3,081
| +13% | +$240K | 0.33% | 88 |
|
|
2014
Q1 | $1.62M | Buy |
22,918
+3,823
| +20% | +$300K | 0.27% | 104 |
|
|
2013
Q4 | $1.43M | Buy |
19,095
+5,644
| +42% | +$393K | 0.24% | 107 |
|
|
2013
Q3 | $845K | Buy |
13,451
+3,005
| +29% | +$180K | 0.16% | 133 |
|
|
2013
Q2 | $536K | Buy |
+10,446
| New | +$544K | 0.1% | 148 |
|
Other funds holding GILD
Trust Company of Vermont's GILD Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in Gilead Sciences (GILD) in Q2 2026: 12,339 shares worth $1.56M. The stake represents 0.06% of the portfolio and ranks #183 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in GILD as recently as Q4 2025.
Trust Company of Vermont first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.99M in Q4 2015. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Trust Company of Vermont held 12,339 shares of Gilead Sciences worth $1.56M as of Q2 2026.
- Gilead Sciences was a new Trust Company of Vermont position in Q2 2026.
- Gilead Sciences made up 0.06% of Trust Company of Vermont's portfolio in Q2 2026, its #183 holding.
- Trust Company of Vermont first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Trust Company of Vermont's Gilead Sciences position peaked at $4.99M in Q4 2015.
- 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.